Hear Lib’s story about being on steroids, having a splenectomy, and then Nplate® treatment.
Ally is worried her current medication isn’t working. She’s ready to talk about her goals and other treatment options.
Tommy tells his doctor about concerns with his current treatment. They talk about his options.
It takes teamwork—but Maura, her mom, and her doctor come up with a game plan for her ITP treatment.
Nplate® helps the body to make more platelets, which can help reduce the risk of bleeding in people with ITP.
For more than 13 years, Nplate® has been helping people who have ITP.
Platelet Disorder Support
Association (PDSA)
A nonprofit organization dedicated
to enhancing the lives of people with
ITP and other platelet
disorders
through education,
advocacy,
research, and support.
ITP Support Association
A UK-registered charity that aims to
promote and improve the general
welfare of people with ITP.
National Heart, Lung, and
Blood Institute
A globally led institute that supports
and conducts heart, lung, and blood
disease research on behalf of the
federal government at the National
Institutes of Health (NIH).
American Society of
Hematology
The world’s largest professional
society working to conquer blood
diseases.
Platelets on the Web
Useful information for physicians,
patients, and caregivers about
immune thrombocytopenia (ITP).
These third-party resources are for your information only. Amgen does not endorse and is not responsible for the content included in these resources. When using these websites and resources, look over the information carefully so you can understand how it applies to your needs. Always talk to your doctor about any questions regarding your ITP treatment.
If you’ve been prescribed Nplate®, you might have questions about your medicine, how it may be covered by your insurance, or resources within your community. That’s why we created Nplate® Navigator—so you have a single place to go to find the support, tools, and resources* most important to you.
*Resources include referrals to independent nonprofit patient assistance programs. Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits’ criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
†Amgen Nurse Navigators are only available to patients that are prescribed certain products. Nurse Navigators are there to support, not replace, your treatment plan and do not provide medical advice or case management services. Patients should always consult their healthcare provider regarding medical decisions or treatment concerns.
Whatever type of insurance you have—even if you have none—Amgen Nurse Navigator can help you understand how your Nplate® medicine may be covered, and refer you to programs that may be able to help you afford it,‡ such as Amgen FIRST STEP™. See below for more information.
For eligible§ commercially insured patients
If you are an eligible commercially insured patient, Amgen FIRST STEP™ can help cover your out-of-pocket prescription costs, including deductible, co-insurance, and co-payment.
‡Provided through independent nonprofit patient assistance programs, program eligibility is based on the nonprofit's criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
§Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal, state, or government-funded healthcare program. Not valid where prohibited by law.
A majority of people pay nothing for Nplate®*
*In an analysis of 25,923 Nplate® claims identified between 1/1/2020 - 12/31/2020, 74% had a $0 out-of-pocket (OOP) cost. This included all payers, including commercial and government plans. Among the 26% of Nplate® claims where patients had OOP costs, most claims (70%) had an OOP cost of less than $500. Data based on IQVIA LAAD claims data.
Call to chat 1-888-4ASSIST (1-888-427-7478) Monday through Friday –
9 AM to 8 PM ET
Important Safety Information
What is the most important information I should know about Nplate®?
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
Higher risk for blood clots:
What are the possible side effects of Nplate®?
How will I receive Nplate®?
Nplate® is given as an injection under the skin (subcutaneous) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
APPROVED USES
Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in:
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS), or low platelet count caused by any condition other than immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
References
1. TK Drem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Important Safety Information
What is the most important information I should know about Nplate®?
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
Higher risk for blood clots: